Published in JAMA, the Journal of the American Medical Association, the study found that the use of Glucagon-like peptide agonists increases the risk of bowel obstruction and gastroparesis
Frias JP, Choi J, Rosenstock J, Popescu L, Niemoeller E, Muehlen-Bartmer I, et al
Because their mechanisms differ, most concerns relate to behavioural overlap rather than chemical conflict
For people who struggled with nausea on tirzepatide, retatrutide offers a slower alternative protocol (2 mg increments over 20 weeks, detailed in our retatrutide dosage guide)
The generic version of Victoza follows the approval of a generic version of Byetta (another GLP-1 receptor agonist) in November
If left undetected, however, melanoma can spread to distant sites or distant organs